Report Summary

Bristol-Myers Squibb Company - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Bristol-Myers Squibb Company (BMS) is a global pharmaceutical and related health care products company. BMS was formed by the merger of Bristol Myers and Squibb Pharmaceuticals in 1989, a move which at the time created the world’s second largest drug company. BMS is headquartered in New York City, New York and employs about 43,000 people. The company recorded revenues of $17,914 million during the fiscal year ended December 2006, compared to the revenues of $19,207 million in 2005 (decrease of 6.7% over 2005). The operating profit was $2,635 million in fiscal year 2006, compared to an operating profit of $4,516 million in 2005. The net profit was $1,585 million in fiscal year 2006, compared to a net profit of $3,000 million in 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available